|
Add this event to your calendar:
|
|
Outlook | Google Calendar | Apple Calendar
|
|
Industry Therapeutic Update from UCB
|
| Monday, April 7, 2025 |
| 6:00-8:00 pm PT |
| San Diego Ballroom A |
| Marriott Marquis |
| San Diego, CA |
|
|
You are invited to join UCB for a dinner program where experts will
discuss the latest thinking and developments around seizure emergencies, including
a new paradigm for rapid and early seizure termination (REST) and acute cluster termination (ACT).
|
|
Speakers
|

Kamil Detyniecki, MD
Associate Professor of Neurology
Director, Clinical Trials/Epilepsy Division
University of Miami Miller School of
Medicine
Miami, Florida
|

Sheryl Haut, MD
Professor of Neurology
Chief of Service, Neurology
Director, Adult Epilepsy
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, New York
|
|
|
| |
Speakers
|
 |
Kamil Detyniecki, MD
Associate Professor of Neurology
Director, Clinical Trials/Epilepsy Division
University of Miami Miller School of
Medicine
Miami, Florida
|
 |
Sheryl Haut, MD
Professor of Neurology
Chief of Service, Neurology
Director, Adult Epilepsy
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, New York
|
| |
|
|
|
How do you define a ‘seizure emergency’?
|
|
When should a rescue medication be used?
|
|
What is the impact of route of administration on time to onset of effect?
|
|
|
These are just a few of the questions that will be asked during this audience participation event.
|
|
We will want to hear from you and your peers!
|
|
This program will aim to meet the following objectives:
|
- Discuss the burden of seizure emergencies and importance of seizure action plans in all phases of life
- Describe the recent consensus recommendations around defining seizure emergencies, including prolonged seizures and seizure clusters
- Examine the available treatment options for terminating a seizure emergency
|
|
|
|
We hope you will join us for this session as we work
together to improve the lives of patients who experience seizures.
|
|
|
|
This program is NOT accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2025 AAN Annual Meeting education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.
|
|
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at this program is limited to healthcare professionals. Accordingly, attendance by guests or spouses is not appropriate, and associated expenses will not be reimbursed. Certain state and federal requirements place restrictions on and/or require disclosure of items UCB provides to healthcare professionals, including meals and refreshments. UCB is committed to complying with all legal requirements.
|
| |
|
©2025 UCB, Inc., Smyrna, GA 30080. All rights reserved.
US-DA-2500176
|
| If you no longer wish to receive emails from us, click here to unsubscribe. |
|
|